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12 Abstract
13 Activity-dependent synaptic plasticity involves rapid regulation of neuronal protein synthesis on a time-scale of minutes. miRNA
14 function in synaptic plasticity and memory formation has been elucidated by stable experimental manipulation of miRNA
15 expression and activity using transgenic approaches and viral vectors. However, the impact of rapid miRNA modulation on
16 synaptic efficacy is unknown. Here, we examined the effect of acute (12min), intrahippocampal infusion of a miR-34a antagonist
17 (antimiR) on medial perforant path-evoked synaptic transmission in the dentate gyrus of adult anesthetised rats. AntimiR-34a
18 infusion acutely depressed medial perforant path-evoked field excitatory post-synaptic potentials (fEPSPs). The fEPSP decrease
19 was detected within 9 min of infusion, lasted for hours, and was associated with knockdown of antimir-34a levels. Antimir-34a-
20 induced synaptic depression was sequence-specific; no changes were elicited by infusion of scrambled or mismatch control. The
21 rapid modulation suggests that a target, or set of targets, is regulated by miR-34a. Western blot analysis of dentate gyrus lysates
22 revealed enhanced expression of Arc, a known miR-34a target, and four novel predicted targets (Ctip2, PKI-1α, TCF4 and
23 Ube2g1). Remarkably, antimiR-34a had no effect when infused during the maintenance phase of long-term potentiation. We
24 conclude that miR-34a regulates basal synaptic efficacy in the adult dentate gyrus in vivo. To our knowledge, these in vivo
25 findings are the first to demonstrate acute (< 9 min) regulation of synaptic efficacy in the adult brain by a miRNA.
26 Keywords microRNA .miR-34a . Gene expression . Hippocampus . Protein synthesis . Synaptic plasticity . Synaptic efficacy
27
28 Introduction
29 The highly pleiotropic nature of miRNAs has changed our
30 view of neuronal development, function and aging. Some
31 60% of human genes may be post-transcriptionally regulated
32 by miRNAs [1, 2], and in the brain, the list of miRNAs im-
33 plicated in neuronal plasticity paradigms is growing [3, 4].
34 Synaptic stimulation resulting in long-term potentiation
35 (LTP) and long-term depression (LTD) have been
36demonstrated to involve tight temporal control of many
37brain-specific miRNAs, suggesting that miRNAs coordinate
38protein expression underlying the plasticity of synaptic trans-
39mission [3, 5–10]. Causal roles for specific miRNAs in LTP
40and LTD mechanisms have been identified using viral vectors
41to chronically knockdown microRNA expression or inhibit
42miRNA binding to target mRNA [11, 12]. Rapid, neuronal
43activity-dependent regulation of the RNA-induced silencing
44complex (RISC) has also been demonstrated [7, 13, 14].
45However, to date, nomiRNAs have been demonstrated to play
46an acute role in regulating synaptic strength on the order of
47minutes.
48miR-34a plays a critical regulatory role in neurodegenera-
49tive diseases such as Alzheimer’s disease (AD) [15], neuro-
50psychiatric disorders such as bipolar disorder [16, 17], and
51schizophrenia [18], in addition to being implicated in devel-
52opment and many forms of cancer [19–21]. miR-34a has
53emerged as a key regulator of cell proliferation, apoptosis,
54and differentiation, and at least 77 targets that have been ex-
55perimentally validated across multiple cell types [19]. miR-
5634a is ubiquitously expressed with the highest abundance in
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57 the brain (and testes) [22]. In neurons, miR-34a has a
58 somatodendritic distribution and it is implicated in the regula-
59 tion of synaptic protein targets [23]. In the rat dentate gyrus
60 in vivo, induction of LTP has been associated with enhanced
61 miR-34a expression in the Argonaute 2/RISC [9] and altered
62 total miR-34a expression in lysates samples [5, 8, 9]. Our
63 previous work identified the immediate early gene Arc as a
64 potential target of miR-34a. In cultured hippocampal neurons,
65 overexpression of miR-34a resulted in downregulation of Arc
66 expression [5]. Intriguingly, no changes in miR-34a were ob-
67 served following brain-derived neurotrophic factor (BDNF)
68 treatment in primary hippocampal neuronal cultures in vitro
69 or following high-frequency stimulation (HFS)-induced LTP
70 in vivo, despite increased Arc expression [5]. In total lysates,
71 we have reported a small increase in miR-34a expression, and
72 a large increase in Ago2-associated miR-34a expression,
73 30 min following LTP induction, in vivo [9]. The work sug-
74 gested a preferential loading of miR-34a into the Ago2/RISC
75 following HFS-induced NMDA-receptor-dependent LTP. In
76 awake rats, miR-34a expression was shown to be reduced
77 20 min after LTP induction in the dentate gyrus, leading the
78 authors to suggest that NMDA receptor-mediated reduction of
79 miRNA levels out-competes an independent process working
80 to increase miRNA expression [24].
81 Given the key role of Arc in activity-dependent synaptic
82 plasticity and memory [25], we wanted to explore the possible
83 role of endogenous miR-34a in regulating Arc expression and
84 synaptic efficacy. Herein, we examined a possible role of en-
85 dogenous miR-34a in the acute regulation of synaptic efficacy
86 at medial perforant path (MPP)-dentate gyrus synapses
87 in vivo. Using acute intrahippocampal infusion of miR-34a-
88 targeting antimiR and corresponding mismatch and scrambled
89 controls, we show that acute inhibition of miR-34a profoundly
90 depresses MPP-evoked field EPSPs. Remarkably, antimiR-
91 34a had no effect on synaptic transmission when infused dur-
92 ing the maintenance phase of LTP. The results suggest that
93 miR-34a plays a central role in regulating basal synaptic
94 efficacy.
95 Materials and Methods
96 Reagents
97 Custom-made locked nucleic acid oligonucleotides antimiR-
98 34a,mismatch antimiR-34a, and scrambled-antimiR-34a were
99 obtained from Exiqon, Qiagen, (1 mM prepared in 1 × PBS).
100 Sequences shown in Table S1. HiPerFect Transfection reagent
101 13.5% (Mat. No. 1029975; Lot No. 139311238; Qiagen) was
102 diluted in PBS and added prior infusion to yield 1 mM and
103 100 μM concentrations. Custom-made 6-FAM™ Fluorescein
104 antimiR-34a and scrambled-miR-34a (1 mM prepared in 1 ×
105 PBS; Exiqon) was used for evaluation of neuronal uptake,
106distribution and localisation. Antibodies used for western blot
107analysis were Arc C7 mouse monoclonal (1:500, sc-17839),
108GAPDHmouse monoclonal (1:1000, sc-32233), PKI-1α goat
109polyclonal (1:1000, sc-1944), from Santa Cruz Biotech, USA
110and BCL11B/Ctip2 rabbit polyclonal (1:200, ABIN487046)
111Aviva Systems Biology, USA, TCF4; TCF7L2 rabbit poly-
112clonal (1:1000, ABIN487067) Aviva Systems Biology,
113USA, UBE2G1 rabbit polyclonal (1:200, ABIN1385714),
114Bioss, USA, and Gnao1 rabbit polyclonal antibody from
115Aviva Systems Biology, USA.
116Electrophysiology and Intrahippocampal Infusion
117in Anesthetized Rats
118Intrahippocampal drug infusion was performed as described
119previously [26]. All experiments were carried out under ethi-
120cal standards approved by the Norwegian Committee for
121Experiments on Animals. The experiments were carried out
122on 57 adult male rats of the Sprague-Dawley strain (Taconic,
123Denmark), weighing 250–350 g. Rats were anesthetized with
124urethane (1.5 mg/kg, i.p.), positioned in a stereotaxic frame,
125and body temperature was maintained at 37 °C with a thermo-
126statically controlled electric heating pad. A concentric bipolar
127stimulating electrode (tip separation 500 μm; SNEX 100;
128Rhodes Medical Instruments, Woodland Hills, CA) was
129lowered into the angular bundle for stimulation of the medial
130perforant path. Stereotaxic coordinates for stimulation were as
131follows (in mm): 7.9 posterior to bregma, 4.2 lateral to the
132midline and 2.5 below the dura.
133A Teflon-coated tungsten wire recording electrode (outer
134diameter of 0.075 mm; A-M Systems #7960) was glued to
135the infusion cannula (30 gauge). The electrode was then cut
136so that it extended 800 μm from the end of the cannula.
137Stereotaxic coordinates for recording in the dentate hilus were
138as follows (in mm): 3.9 posterior to bregma, 2.3 lateral and
1392.8–3.1 below the dura. The recording electrode was slowly
140lowered into the dorsal hippocampus until a positive-going
141field EPSP (fEPSP) of maximum slope was obtained in the
142dentate hilus. The tip of the infusion cannula was located in
143the deep striatum lacunosum-moleculare of field CA1,
144800 μm above the hilar recording site and 300–400 μm above
145the medial perforant synapse. The infusion cannula was con-
146nected via a polyethylene (PE50) tube to a 10-μl Hamilton
147syringe (Reno, NV) and infusion pump. After baseline record-
148ing for 20min, 1 μl drug (100μMor 1mM in PBS, 13.5%HP
149transfection reagent, lot no. 139311238, Qiagen) was infused
150for 12 min at a rate of 0.085 μl/min. Evoked responses were
151recorded for 140 min after infusion. Biphasic rectangular test
152pulses of 150-μs duration were applied every 30 s throughout
153the experiment (0.033 Hz). Responses were allowed to stabi-
154lize for 1 h at a stimulation intensity that produced a popula-
155tion spike 30% of maximum. A stable 20-min baseline of
156evoked potentials was recorded (pulse-width 0.15 ms, at
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157 0.033 Hz) before intra-hippocampal drug infusion. Evoked
158 responses were recorded for 120 min post-infusion. Signals
159 from the dentate hilus were amplified, filtered (0.1 Hz to 10
160 kHz), and digitized (25 kHz). Acquisition and analysis of field
161 potentials were accomplished using Datawave Technologies
162 Software. The maximum slope of the fEPSP was measured,
163 and averages of four consecutive responses were obtained.
164 Changes in the fEPSP slope were expressed in percent of
165 baseline (20-min preceding infusion). Responses for input-
166 output (I/O) curves were collected immediately before base-
167 line recording and at 30min and 150 min post-infusion. Seven
168 stimulus intensities ranging from 100 to 1000μAwere applied
169 in randomized sequence.
170 Dissection of the Adult Rat Hippocampal Dentate
171 Gyrus
172 After recordings were completed, the electrodes were re-
173 moved, rats were decapitated and DG microdissection was
174 carried out within 2–3 min. The brain was removed from the
175 skull and placed onto an ice-cold glass slide where it was
176 continuously rinsed with ice-cold PBS. The cerebellum was
177 removed and hemispheres where separated using a scalpel
178 along the cerebral longitudinal fissure. The hemispheres were
179 placed dorsal side down. Forceps were used to lift the brain
180 stem exposing the corpus callosum and the medial side of the
181 hippocampus. The hippocampus was tilted out from the tem-
182 poral cortical fold. Fimbria and blood vessels were removed.
183 Forceps were carefully inserted into the hippocampal fissure
184 isolating the DG from the region of Cornu Ammonis, along its
185 septotemporal axis. The microdissected DGs were immediate-
186 ly frozen on dry ice and stored at − 80 °C until use.
187 Microscopy
188 FAM-labelled antimiR-34a and SC-miR-34a expression in
189 hippocampal neurons was imaged on Axio Imager 2 Zeiss
190 light fluorescent microscope.
191 Cell Culture and antimiR-34a Transfection
192 Normal rat kidney cells (NRK) were maintained in
193 Dulbecco’s modified Eagle medium (DMEM, Sigma) supple-
194 mented with 10% heat-inactivated foetal calf serum (Sigma),
195 100 U/ml penicillin (Sigma), 100 μg/ml streptomycin (Sigma)
196 and 1 mM L-glutamine at 37 °C and 5% CO2. Cells were
197 seeded in 12-well plates at a density of 8000 cells/ml.
198 Hippocampal neuronal cultures were prepared with slight
199 modifications from the protocol originally described by
200 Banker and co-workers [27, 28]. Hippocampi of Wistar rat
201 embryos (E18) were dissected and dissociated by trypsin treat-
202 ment followed by trituration. After removal of trypsin, neu-
203 rons were plated at a density of 200,000 cells/well in a 12-well
204plate for biochemical analysis. Plates were precoated with
205poly-D-lysine (Sigma). The cultures were maintained in
206MEM (M2279, Sigma) growth medium supplemented with
207B-27 supplement (B-27® Supplement, Invitrogen), sodium
208bicarbonate, glucose, and pyruvate, that had been conditioned
209on astrocyte cultures for 3 days. Half of the neuronal growth
210medium was replaced with fresh growth medium twice a
211week. Hippocampal neurons were transfected at 8 DIV.
212AntimiR-34a and SC-miR-34a were transfected at a final con-
213centration of 1 mM using HiPerFect Transfection reagent di-
214luted to 13.5% in PBS.
215The Q2transfectionmixwas replacedwith conditioned growth
216medium (neurons) or complete DMEM medium (NRK cells)
217after 3 h. Cells were washed with once with PBS and harvest-
218ed in RNA lysis buffer (PureLink®miRNA Isolation Kit (Life
219technologies, Invitrogen, Carlsbad, CA, USA) after 48 h.
220Cell Culture and Fluorescent-Labelled antimiR-34a
221Primary hippocampal neuronal cultures were prepared from
222embryonic day 18 (E18) Sprague-Dawley rat brains [29, 30].
223Cells were plated on coverslips coated with poly-L-lysine (100
224μg/ml) and laminin (2 μg/ml) at a density of 30,000/well.
225Hippocampal cultures were grown in Minimum Essential
226Medium (MEM) supplemented with B27, glutamate, sodium
227bicarbonate, glucose, glutamate, pyruvate and antibiotic (peni-
228cillin/streptomycin/neomycin) and added to astrocyte growing
229plate. Fifty percent of the MEM was replaced every 3 days.
230Fourteen DIV neurons were incubated for 2 h with 1 μl (1
231mM) fluorescent-labelled antimiR-34a or SC-miR-34a diluted
232in 400-ml medium, followed by 10-min fixation by 4% para-
233formaldehyde/4% sucrose in PBS at room temperature. After
234fixation cells were washed three times in PBS for 30 min at
235room temperature. Slides were mounted using FluoroGold
236mounting medium with DAPI (Invitrogen) and image acquired
237on Axio imager 2 Zeiss light fluorescent microscope.
238Q-PCR
239To validate the inhibition of microRNAs after antimiR-34a
240transfection, RNA enriched in small RNAs was purified using
241PureLink®miRNA Isolation Kit (Life technologies, Invitrogen,
242Carlsbad, CA,USA). Changes inmaturemicroRNA levels were
243determined using the TaqMan® MicroRNA Reverse
244Transcription Kit and TaqMan® microRNA Assays (Applied
245Biosystems, Foster City, CA) according to the manufacturer’s
246protocol. Fifteen microliters of cDNAwas generated from 30 ng
247of total RNA, and 3 μl of a 15-fold dilution was used for real-
248time PCR reactions. The data was normalized to Y1. Changes in
249relative concentrationwere calculatedwith the second derivative
250maximummethod 2−ΔCT. ΔCTwas calculated by subtracting the
251CTof the geometric mean of the two housekeeping genes from
252the CT of the gene of interest.
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253 RNA Preparation
254 Micro-dissected dentate gyri were homogenized in a
255 Dounce homogenizer on ice in lysis buffer (20 mM
256 Tris, pH 7.5, 150 mM NaCl, 2 mM MgCl, 1 mM
257 NaF, 0.5% DTT, 2 mM EDTA, protease inhibitor,
258 RNAse inhibitor, DEPC water), and protein concentra-
259 tion was determined using the Pierce BCA protein assay
260 reagent (Thermo Scientific, Pierce).
261 SDS-PAGE and Western Blotting
262 Equal protein amounts (40 μg) were loaded onto 8% or
263 10% SDS-PAGE gels and run for 2 h at a constant
264 voltage of 100 V. Separated proteins were subjected to
265 western blotting and transferred to HyBond ECL nitro-
266 cellulose membrane (Amersham, Little Chalfont, UK) at
267 a constant voltage of 100 V for 1.5 h. Membranes were
268 stained with Ponceau to check for proper transfer
269 followed by blocking with buffer (5% BSA, 0.1%
270 Tween and Tris-buffered saline (TBST) for 1 h on a
271 gyro-rocker at room temperature. The primary and sec-
272 ondary antibodies were diluted in 5% BSA in 0.1%
273 TBST, and 0.1% TBST, respectively. The membranes
274 were incubated with primary antibody over night at 4
275 °C on a gyro-rocker. Following three washes of TBST,
276 blots were incubated for 1 h in horseradish peroxidase-
277 conjugated secondary antibody dissolved in TBST at
278 room temperature. The blots were washed three times
279 with TBST, and proteins were visualized using en-
280 hanced chemiluminescence (ECL Western Blotting
281 Analysis System, Amersham Pharmacia Biotech,
282 Norway). The blots were scanned using Gel DOC
283 XRS+ (BIO RAD), and densitometric analyses were
284 performed with ImageJ software (NIH, Bethesda, MD).
285 miRNA Target Prediction
286 miRNA target prediction sources have been described
287 elsewhere [9]. To identify the putative target genes of
288 each miRNA, we first queried four of the most widely
289 used target prediction sources: DIANA [31], miRanda
290 [32], TargetScan [33] and PicTar [34]. We quantified
291 the agreement between predicted target lists using
292 Rank Product (RP) analysis [35]. Each gene was or-
293 dered by quality score and the geometric mean of the
294 gene rank calculated across prediction sources. Missing
295 ranks were imputed for target genes missing only one
296 rank value, and genes missing more source values were
297 discarded. To assess the robustness of the computed
298 ranks, we performed a bootstrap analysis with 1000
299 permutations of rank order using the Bioconductor
300 RankProd package [36].
301Results
302Given that miR-34a is implicated in the regulation of synaptic
303protein targets, it presents as an attractive candidate to manip-
304ulate for investigation of synaptic function and plasticity. In
305order to investigate the function of miR-34a the dentate gyrus
306in vivo, initial experiments were carried out in vitro for veri-
307fication of antimiR uptake in cells, cellular distribution and
308efficiency of miRNA knockdown.
309AntimiR Downregulates Endogenous miRNA 34a
310First, we tested endogenous knockdown of miR-34a in NRK
311cells. RNA enriched for small RNAs was isolated 48 h after
312transfection of antimiR-34a and scrambled-miR-34a (SC-
313miR-34a) control, and the level of unbound microRNA was
314assayed byRT-PCR. Approximately 8% ofmiR-34a remained
315unblocked after specific antimiR-34a transfection compared
316to control (Fig. 1a), demonstrating a 92% knockdown of en-
317dogenous miR-34a in vitro. Y1 RNAwas used for normaliza-
318tion. Functional miRNA inhibition was also assessed in den-
319tate gyrus in vivo. Taqman qPCR was performed on dentate
320gyrus total homogenates 2 h after intrahippocampal infusion
321of SC-miR-34a or antimiR-34a (sequences listed in
322Supplementary data Table S1). Results revealed that
323antimiR-34a downregulated endogenous miR-34a 0.5-fold
324compared to SC-miR-34a control (Fig. 1b). Significance was
325tested by one-way ANOVA (*p < 0.05). These results indicate
326that antimiR-34a is a potent inhibitor of endogenous miR-34a
327in cell cultures in vitro and in the hippocampus of live rats.
328AntimiR-34a Is Detected in Cell Bodies and Dendrites
329of Hippocampal Neurons
330To evaluate neuronal uptake, distribution and localization, an
331antimiR-34a uptake experiment was conducted using cultured
332primary hippocampal neurons. AntimiR-34a and scrambled-
333miR-34a were labelled with green fluorescent dye (FAM-6,
334Exiqon) and added (1 μl, 1 mM) to the culture medium (400
335ml) followed by an incubation period of 2 h. Fluorescence
336microscopy showed uptake of FAM-labelled antimiR-34a
337and SC-miR-34a by primary hippocampal neurons. FAM-6-
338antimiR-34a distribution was somatodendritic similar to en-
339dogenous miR34a (Fig. 2), whereas FAM labelled SC-miR-
34034a was more soma restricted. These results indicate effective
341neuronal uptake and somatodendritic distribution of antimiR-
34234a.
343miRNA-34a Acutely Regulates Synaptic Efficacy
344We asked whether miR-34a is involved in the regulation of
345basal synaptic efficacy in the dentate gyrus of the adult anes-
346thetized rat. AntimiR-34a and scrambled antimiR-34a were
Mol Neurobiol
JrnlID 12035_ArtID 1816_Proof# 1 - 09/11/2019
AUTHOR'S PROOF
U
N
C
O
R
R
EC
TE
D
PR
O
O
F
347 infused into deep stratum lacunosum-moleculare of dorsal
348 CA1, immediately above the dentate gyrus (1 μl, 12 min).
349 Infusion of SC-antimiR-34a (grey circles, n = 13) served as
350 a control to distinguish sequence-specific silencing from non-
351 specific effects. Figure 3a shows the experimental design. No
352 effects were observed on MPP-evoked responses post-
353 infusion of SC-antimiR-34a throughout the recording
354 (Fig. 3b). Strikingly, infusion of antimiR-34a (black cir-
355 cles, n = 12) elicited a decrease of the MPP-evoked
356 fEPSP. Already ~ 9min after completing antimiR-34a infusion,
357 the fEPSP slope started to progressively decrease. During the
358 140-min recording post-infusion, the fEPSP decreased to ~
359 60% below baseline (Fig. 3b, c). Input-output curves obtained
360during baseline (1), 30 min post-infusion (2) and 150 min after
361time point of infusion (3) (Fig. 3e) show a decrease in synaptic
362transmission across a range of stimulus intensities. Figure 3d
363shows representative sweeps collected at five time points be-
364fore and after infusion (as labelled in Fig. 3b).
365To further assess the specificity of the antimiR-34a effect,
366rats were infused with mismatch-antimiRNA-34a (MM-
367antimiR-34a, striped triangles, n = 6) harbouring nucleotide
368mismatches at nucleotides 2, 6, and 10 in the 15-nt sequence
369(Supplementary S1). Similar to scrambled miR-34a, infusion
370of MM-antimiR-34a did not impact field EPSP slope values
371across the duration of recording (Fig. 3b), and no difference
372was found between pre and post-infusion input-output curves
373(Fig. 3e) (p > 0.05). These results indicate that perfect base pair
374complementarity at miR-34a nucleotides 2, 6 and 10 are crucial
375for inhibition of endogenousmiR-34a and acute downregulation
376of synaptic transmission. Previously, we identified Arc-targeting
377miRNAs and showed that overexpression of both miR-34a and
378miR-193 inhibits Arc expression in cultured hippocampal neu-
379rons. In adult dentate gyrus, miR-193 has a somatodendritic
380expression profile similar to miR-34a. However, as shown in
381Fig. 3a, infusion of antimiR-193 (white circles, n = 6) did not
382elicit a change in MPP-evoked fEPSPs. The robust effect of
383antimiR-34a and complete lack of effect of SC-miR-34a, MM-
384antimiR-34a, and antimiR-193 indicates a profound role of en-
385dogenous miR-34a in regulation of basal synaptic efficacy
386in vivo. Western blots on total homogenates showed that
387antimiR-34a enhances expression of Arc 3.1-fold in the ipsilat-
388eral infused dentate gyrus relative to control (Fig. 5a, b), whereas
389scrambled miR-34a and mismatched antimiR-34a controls had
390no significant effect (n = 6, p > 0.05).
391LTP Induction Blocks Antimir-34a-Mediated
392Depression
393Next, we sought to inhibit endogenousmiR-34a during LTP in
394the dentate gyrus of the adult anaesthetised rat in vivo. Our
395previous work has shown that Arc translation is necessary for
396LTP consolidation [26] and that miR-34a downregulates Arc
397protein in vitro [5]. Given the profound depression of synaptic
398transmission elicited by antimiR-34a at baseline, wewanted to
399assess the effect of antimiR-34a infusion during the mainte-
400nance phase of LTP. We speculated that if miR-34a is
401derepressed following high-frequency stimulation (HFS)-in-
402duced LTP, the effect of antimiR-34a infusion during the LTP
403maintenance phase may be attenuated. Figure 4a shows the
404experimental design. HFS (400 Hz, 8-pulse bursts) of the me-
405dial performant path (MPP) generated a lasting increase in the
406slope of the fEPSP. AntimiR-34a or SC-miR-34a was infused
407(1 μl/12 min) at 2 h post-HFS, and recording was continued to
4084 h post-HFS. Time course plots are shown in Fig 4c.
409Remarkably, infusion of antimiR-34a during LTP mainte-
410nance had no effect on fEPSPs recording over the 2-h post-
Fig. 1 AntimiR downregulates endogenous microRNA. a RNA enriched
for small RNAs was isolated 48 h after transfection of antimiR and
scrambled control, and the level of unbound microRNAs was assayed
by real-time PCR. Approximately 8% of miR-34a remained unblocked
after specific antimiR-34a transfection compared to scrambled control.
Y1 was used for normalization. b Taqman qPCR was performed on
dentate gyrus total homogenates 2 h after infusion of scrambled
antimiR-34a or antimiR-34a. Bar graphs shows relative miRNA-34a
expression levels post-antimiR-34a (n = 6) and SC-antimiR-34a (n = 4)
treatment. AntimiR-34a reduced endogenous miR-34a levels by 50%
compared to SC-miR-34a control. Normalised to Y1 and SNO. Values
are means of ± S.E.M. One-way ANOVA analysis was used to test
significance between groups (*p < 0.05)
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411 infusion period, and there was no difference between antimiR-
412 34a and SC-miR-34a groups in LTP magnitude recorded 4 h
413 post-HFS. Figure 4b shows representative sweeps collected at
414 five different time points before and after HFS and drug infu-
415 sion (indicated in Fig. 4c).Western blot analysis performed on
416 whole dentate gyrus lysates confirmed upregulation of Arc
417 protein 4 h post-HFS, but there was no significant dif-
418 ferences in Arc levels between antimiR-34a (n = 5) and
419 SC-miR-34a (n = 6) infused rats (Fig. 4d). Significance
420 was tested by one-way ANOVA (*p < 0.05).
421 mRNA Target Prediction
422 To better understand the downstream effects of antimiR infu-
423 sion, we integrated predictions from four miRNA target pre-
424 diction resources: PicTar [34], TargetScan [33], Miranda [32]
425 and DIANA [31]. We used the rank product method [35, 36]
426 where ranks are aggregated across prediction resources using
427 a geometric mean where a gene must appear in at least two
428 sources. This allowed us to mitigate for the poor agreement
429 normally found between different target gene prediction algo-
430 rithms. miR34a was predicted to target 397 genes
431 (Supplementary S2). Using the Bioconductor KEGG profile
432 package, the common targets were predicted to be involved in
433 96 pathways (Supplementary S3), including regulation of the
434actin cytoskeleton, LTD, MAPK signalling, axon guidance
435and the calcium signalling pathway. Five predicted targets
436were selected as candidates for Western blot analysis:
437Bcl11b/Ctip2 (from now on referred to as Ctip2), Ube2g-11,
438TCF4, PKI-1α and Gnao1. Ctip2, COUP-TF interacting pro-
439tein 2, is expressed predominantly in central nervous system
440(CNS). In the dentate gyrus, loss of Ctip2 expression selectiv-
441ity impairs spatial working memory [37]. TCF4 is a transcrip-
442tion factor known to regulate synaptic plasticity and memory
443function [38]. Ube2g1 is involved in mechanisms targeting
444abnormal or short-lived proteins for degradation [39]. PKI-
4451α negatively modulates synaptic activity [40]. Gnao1 is
446brain-enriched and mutations in the gene are associated with
447epileptic encephalopathy [41].
448miRNA-34a Regulates Multiple Targets in Addition
449to Arc in the Dentate Gyrus In vivo
450Next, we investigated the effects of acute intrahippocampal
451infusion of antimiR-34a on Arc protein expression along with
452the five new predicted miR-34a targets Ctip2, PKI-1α, Ube2g-
45311, TCF4 and Gnao1 protein expression. Dentate gyri were
454micro-dissected 140 min after infusion of antimiR-34a or con-
455trol sequences. Replicating results from Fig. 3, antimiR-34a
456infusion elicited a stable decrease of the fEPSP slope to ~
Fig. 2 AntimiR-34a is detected in cell bodies and dendrites of
hippocampal neurons. Cultured hippocampal neurons (DIV 14) were
treated with fluorescent antimiR-34a or scrambled antimiR-34a for 2 h.
Expression was assessed by light microscopy. a, b Representative image
of cells treated with fluorescent scrambled miR-34a. c, d Representative
images of cells treated with antimiR-34a. AntimiR-34a is detected in the
somata and the dendrites. e Dapi stained control, no fluorescence
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457 60% of baseline.Western blot analysis of dentate gyrus homog-
458 enates showed significantly enhanced expression of Arc (3.1-
459 fold, n = 6, p > 0.05), Ctip2 (1.6-fold, n = 13, p > 0.05), PKI-1α
460 (2.2-fold, n = 10, p > 0.05), Ube2g-1 (1.5-fold, n = 10, p > 0.05)
461 and TCF4 (2.6-fold, n = 6, p > 0.05) in the antimiR-infused
462 dentate gyrus relative to the contralateral dentate gyrus, which
463was significantly different from the MM-antimiR-34a and SC-
464miR-34a controls (Fig. 5a, b). There was no statistically signif-
465icant alteration in Gnao1 expression (n = 12, p < 0.05), or
466difference between groups indicating that Gnao1 is not regulat-
467ed by miR-34a under the present conditions. GAPDHwas used
468as a loading control and for normalisation.
Fig. 3 miRNAQ3 -34a regulates synaptic efficacy, and variation in sequence
alters target recognition. a Experimental design. b Time course plots
show changes in the medial perforant path-evoked fEPSP slope
expressed in percentage change from baseline. Values are means ±
S.E.M. Infusion of scrambled antimiR-34a and antimiR-34a is indicated
by vertical, dotted lines. Synaptic efficacy is rapidly and gradually
reduced to ~ 60% after local infusion (1 μl, 1 mM) of antimiR-34a
(black circles, n = 12). Infusion of the multiple controls scrambled
antimiR-34a (grey circles, n = 13), or mismatched antimiR-34a (striped
triangles, n = 6) or antimiR-193 (white circles, n = 6), had no effect on
synaptic efficacy. c Bar graph of % fEPSP slope change from baseline. d
Representative progression sweeps of scrambled antimir-34a, antimiR-
34a, antimiR-193, mismatch antimiR-34a during baseline (1), 20 min
post-infusion (2), 60 min post-infusion (3), 90 min post-infusion (4),
and 120 min post-infusion (5). Averaged field potentials traces (20
sweeps) collected at the beginning of baseline recording (1), 20 min
after infusion (2), 60 min post-infusion (3), 90 min post-infusion (4),
and 150 min post-infusion (5). Scale bars 5 mV, 2 ms. e Input-output
curves (average of 4 sweeps) collected at baseline (20 min), post-
infusion (30 min) and at the end of the experiment (150 min).
Significance was tested by factorial ANOVA, and post hoc tests. A
probability level of p < 0.05 was considered statistically significant (b =
*p < 0.05, c = **p < 0.01, and d = ***p < 0.001)
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469 Discussion
470 Synaptic plasticity such as LTP, LTD and homeostatic synap-
471 tic scaling are alterations of synaptic transmission and efficacy
472 in response to neural activity. Long-lasting activity-dependent
473 modifications of synapses typically require de novo protein
474 synthesis. In addition to somatic protein synthesis, translation
475 of mRNA in dendritic processes is important for synaptic
476homeostasis and plasticity [42, 43]. Many miRNAs are in-
477volved in the spatial-temporal control of neuronal protein syn-
478thesis and regulation of synaptic plasticity. MicroRNA func-
479tion has been elucidated primarily through loss-of-function
480approaches in which a specific miRNA is deleted or chroni-
481cally inhibited, and by viral vector-mediated miRNA overex-
482pression [7]. However, the regulation of protein synthesis dur-
483ing activity-dependent synaptic plasticity operates on a
Fig. 3 (Continued)
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484 timescale of minutes. To our knowledge, the present study is
485 the first to report acute regulation of synaptic efficacy in the
486 adult brain by a miRNA.
487 We found that brief (12 min) intrahippocampal infusion of
488 antimiR-34a results in a rapid and persistent decrease in
489 MMP-evoked synaptic transmission in the dentate gyrus.
490 The decrease in fEPSP started at approximately 9 min after
491 completing the infusion and developed gradually, reaching a
492 stable 60% decrease relative to pre-infusion baseline. This
493 modulation was absent when a scrambled or mismatched
494miR-34a sequence was introduced. Levels of endogenous
495antimiR-34a in the dentate gyrus were downregulated by
496antimiR-34a, but not by infusion of scrambled control se-
497quence. Furthermore, antimiR-34a but not control sequences
498resulted in upregulation of Arc, a known miR-34a target and
499major regulator of synaptic plasticity. AntimiR-34a infusion
500similarly resulted in sequence-specific upregulation of several
501novel predicted miR34a targets (Ctip2, PKI-1α, TCF4 and
502Ube2g) with roles in neuronal and synaptic function. This
503suggests that endogenous miR-34a potently regulates synaptic
Fig. 4 LTP induction blocks
miRNA-34a-mediated depression
of synaptic transmission. a
Experimental timeline. b
Representative sweeps collected
at baseline (20 min) (1), 5 min
post-HFS (2), 130 min post-HFS
(3) and 240 min post-HFS (4). c
Time course plots show changes
in the medial perforant path-
evoked fEPSP slope expressed in
percentage of baseline. Values are
means ± S.E.M. Scale bars 5 mV,
2ms. Vertical dotted lines indicate
infusion (1 μL/12 min). HFS is
indicated by black arrow
(antimiR-34a, n = 5; SC-miR-
34a, n = 6). Dentate gyrus tissue
was collected 2 h post-infusion. d
Western blots were performed in
dentate gyrus homogenates 4 h
after HFS and 2 h after infusion of
antimiR-34a or SC-miR-34a
during LTP. Arc protein is
significantly enhanced during
LTP, but there is no significant
difference between the two
groups (n = 4 in both groups)
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504 transmission through sequence-specific inhibition of one or
505 more target RNAs. Release of the tonic inhibition mediated
506 by miR-34a resulted in profound depression of synaptic trans-
507 mission. Remarkably, antimiR-34a had no effect on synaptic
508 efficacy when infused at 2 h post-HFS, during the process of
509 Arc-dependent LTP consolidation.
510 MiR-34a Regulation of Arc and Synaptic Efficacy
511 In vivo
512 The speed at which antimiR-34a impacts synaptic transmis-
513 sion suggests that the effective target mRNAs are located near
514 synapses, such that newly synthesized proteins can exert a
515nearly immediate effect on synaptic efficacy. Arc is a miR-
51634a target that may fit such a role.
517The diversity of Arc function in synaptic plasticity is a truly
518remarkable phenomenon. Arc scales neuronal action and con-
519trols excitation and inhibition through bidirectional regulation
520of synaptic strength. Synaptic activity can converge to alter
521Arc transcription and then diverge to induce different plastic-
522ity outcomes, such as AMPA-receptor endocytosis promoting
523LTD or actin cytoskeletal modulation promoting LTP [26, 42,
52443]. In this study, we initially chose to explore miR-34a func-
525tion in vivo due to its Arc-targeting properties shown in vitro
526[5]. We hypothesised that knockdown of miR-34a would en-
527hance Arc expression and alter synaptic efficacy. Here,
Fig. 5 AntimiR-34a infusion
enhances synaptic protein
expression during basal
conditions. Western blots were
performed in dentate gyrus
homogenates 2 h after infusion of
scrambled antimiR-34a, antimiR-
34a, and mismatched anitmiR-
34a during baseline conditions.
Immunoblots on total
homogenates (left/right
hemisphere ratio) showed that
antimiR-34a enhances expression
of different protein. a Mean and
standard deviation of the protein
levels detected in western
blotting. One-way ANOVAwith
Tukey’s post hoc analysis was
used to test significance between
groups compared to control (*p <
0.05, **p < 0.01). b
Representative blots of dentate
gyrus protein expression 2 h post-
infusion of scrambled antimiR-
34a, antimiR-34a, and
mismatched anitmiR-34a, relative
to right hemisphere control,
during baseline conditions
Mol Neurobiol
JrnlID 12035_ArtID 1816_Proof# 1 - 09/11/2019
AUTHOR'S PROOF
U
N
C
O
R
R
EC
TE
D
PR
O
O
F
528 infusion of antimiR-34a increased Arc expression 3-fold and
529 acutely depressed MMP-evoked fEPSPs.
530 Arc is an immediate early gene with low levels of basal
531 expression [44]. Stimulus-evokedArc transcriptionmay occur
532 within minutes [45, 46], and a large fraction of the new
533 mRNA is transported into dendrites where it accumulates in
534 region of activated synapses, presumably to be translated lo-
535 cally [47]. Because Arc mRNA is subject to translation-
536 dependent degradation, it needs to be translationally repressed
537 in order to reach synapses on distal dendrites [48–50]. The
538 precise dendritic spatiotemporal mechanisms regulating Arc
539 mRNA translation and repression of translation are yet to be
540 elucidated. However, in the CA1 region of the hippocampus,
541 application of the metabotropic glutamate receptor agonist
542 (S)-3,5-dihydroxyphenylglycine (DHPG) induces a
543 transcription-independent LTD that requires translation of
544 dendritic Arc and expression of protein within 10 min of treat-
545 ment [51]. In isolated synaptoneurosome preparations,
546 in vitro stimulation with BDNF induces Arc protein syn-
547 thesis in a time range of 10–30 min [52, 53]. As men-
548 tioned, Arc translation is necessary for LTP consolida-
549 tion in vivo. The process depends on the provision of
550 newly transcribed Arc, and Panja et al. [26] showed that
551 Arc mRNA shifts from the monosome/mRNP fraction to
552 polysomes during LTP consolidation. Recent imaging
553 studies from hippocampal neuronal cell cultures also
554 suggest that, at the basal state, Arc mRNA in dendrites
555 is held quiescent in stalled polysomes. In response to
556 glutamate stimulation, Arc is translated in less than
557 1 min [54]. Given the profound effect of antimiR-34a
558 at the basal state, it is tempting to consider that en-
559 hanced expression of Arc and other miR34a targets is
560 due to activation of mRNA on stalled polysomes. Both
561 Arc mRNA and miR-34a are found in the excitatory
562 synaptic compartment of the dentate gyrus at the
563 unstimulated basal state [5].
564 The selective modulation of basal transmission by antimir-
565 34a, with no effect on established LTP, is extraordinary and
566 the underlying mechanism is unknown. The lack of effect
567 during the LTP state might be due to (1) inability of
568 antimiR-34a to access miR-34a or (2) degradation of
569 the relevant miR-34a pool. Previously we reported that
570 LTP induction in the dentate gyrus of urethane-
571 anesthetized rats is associated with increased, NMDAR-
572 dependent association of miR-34a with the Ago2/RISC [9].
573 Perhaps this process of miR-34a loading onto Ago2 inhibits
574 antimiR binding. Assuming miR-34a regulates a preexisting
575 pool of Arc mRNA on stalled polysomes, it is possible that
576 miR-34a is degraded or sequestered in P-bodies following
577 HFS-induced translation. In this case, the basis for antimir-
578 34a induced synaptic depression will be lost. A third possibil-
579 ity, so far unexplored, is that newly synthesized Arc mRNA
580 [53] is immediately translated, thus bypassing the stage of
581miR-34a binding and repression. In terms of the action of
582the Arc protein itself, to enhance or depress synaptic trans-
583mission, this is known to be dependent on the cell sig-
584naling context [25].
585miR-34a Regulation of Novel Predicted Targets: Ctip2,
586TCF4, PKI1-α and Ube2g1
587The bioinformatic mRNA target prediction and the in vivo
588evidence allows us to suggest four novel miR-34a targets.
589However, they are not formally identified as targets by muta-
590tion of miRNA binding sites. Here, we show that acute inhi-
591bition of miR-34a initiates acute upregulation of Arc along
592with four additional bioinformatically predicted targets of
593miR-34a: Ctip2, PKI-1α, TCF4 and Ube2g.
594Ctip2 is a C2H2 zinc-finger transcription factor, highly
595expressed in dentate granule cells. Selective ablation of
596Ctip2 in the adult dentate gyrus results in morphological
597changes leading to functional impairment [39]. Experiments
598in cultured striatal cell lines indicate that Ctip2 regulates a
599multitude of genes, and enhances brain-derived neurotrophic
600factor (BDNF) signalling [55] which activates cascades such
601as PLC/PKC, PI3K/Akt, Ras/Erk, AMPK/ACC and NFκB
602pathways [56]. BDNF plays a critical role in plasticity at glu-
603tamatergic and GABAergic synapses by both pre- and post-
604synaptic mechanisms [57] and contributes to both acute and
605homeostatic alterations in hippocampal synaptic function
606[58]. BDNF is also known to enhance Arc expression. Thus,
607Ctip2 regulation could potentially impact synaptic transmis-
608sion indirectly. However, the rapid decrease in synaptic trans-
609mission is less likely to involve transcription and regulation of
610BDNF secretion and signalling.
611TCF4 is a transcription factor known to regulate synaptic
612plasticity and memory function [38]. TCF4 haploinsufficient
613mice has been studied as an animal model of autism spectrum
614disorder. These TCF4-deficient mice have impaired Arc ex-
615pression and enhanced LTP induction in hippocampal region
616CA1. In our investigation of antimiR-34a effect, expression of
617TCF4 and Arc protein were both enhanced while basal syn-
618aptic transmissionwas depressed. Though the mechanisms are
619unknown, the opposite effects on synaptic transmission are
620consistent with a homeostatic role of Arc. Interestingly, abla-
621tion of TCF4 results in downregulation Ube2g1 gene tran-
622scription, another predicted target of miR-34a [59]. Our west-
623ern blots on total homogenates showed that infusion of
624antimiR-34a enhances Ube2g1 expression 1.5-fold during
625basal conditions. However, Ube2g1 is not a dendritically lo-
626cated transcript [60]. This indicates that our observed increase
627in Ube2g1 expression may be secondary to enhanced TCF4
628expression, not a result of direct miR-34a-mediated mRNA
629derepression. Mechanisms involving somatic translation of
630Ube2g1 do not present a likely explanation for the observed
631acute modulation of synaptic efficacy.
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632 PKI-1α is a member of the cAMP-dependent protein ki-
633 nase (PKA) inhibitor family. PKA enhances excitatory synap-
634 tic transmission in the dentate gyrus [61], whereas PKI nega-
635 tively modulates synaptic activity and regulates gene expres-
636 sion induced by PKA [61]. In the dentate gyrus, PKI1α
637 mRNA and protein is down regulated by strong depolarization
638 [62]. However, chronic infusion of antisense oligonucleotides
639 against PKIα into the rat brain results in a dramatic reduction
640 of excitability and ability to exhibit LTP and LTD [62]. Here,
641 we demonstrate that infusion of antimiR-34a during baseline
642 conditions results in a 2.2-fold increase in PKI1α protein ex-
643 pression. However, if PKI1α is a direct mRNA target regulat-
644 ed by miR-34a, we would expect an effect of antimiR-34a
645 infusion also during LTP.
646 Gano1 (G protein subunit alpha 1) constitutes up to 0.5% of
647 cerebral membrane protein [63], and mutations in Gnao1 are
648 linked to epileptic encephalopathy [41], indicating an impor-
649 tant role in brain function. Here, western blots on total homog-
650 enates show that loss of miR-34a action does not initiate syn-
651 thesis of Gano1, indicating that Gano1 is not implicated in
652 acute regulation of synaptic transmission during baseline con-
653 ditions in the dentate gyrus.
654 miR-34a Regulation of Synaptic Transmission
655 in Relation to Brain Disorders
656 As neuroscientists, a major aim in understanding the function
657 of miR-34a and regulation of its target genes is to contribute to
658 new knowledge that can aid the development of novel treat-
659 ment strategies for people with psychiatric and neurodegener-
660 ative brain disorders. Addressing neuropathology through
661 antimiR strategies may be available in the near future, and
662 the multiple benefits in using antimiR strategies have been
663 described elsewhere [64, 65]. miR-34a targets genes that are
664 linked to synaptic plasticity, energy metabolism and resting
665 state network activity, and it plays a critical regulatory role
666 in neurodegenerative diseases [15–18]. miR-34a’s role in
667 AD is far from elucidated, but there is increasing evidence
668 of miR-34a’s significance. miR-34a up- or downregulation,
669 manipulation by overexpression or abolishment, all aid our
670 work in understanding its memory-related mechanisms. A re-
671 cent study by Sakar et al. showed that miR34-a overexpres-
672 sion induces rapid cognitive impairment and AD-like pathol-
673 ogy in mice [66]. Conversely, others have shown that rats
674 overexpressing miR-34a in the brain have better learning abil-
675 ities and reduced emotionality [21]. AD model mice injected
676 with antimiR targeting the complete miR-34 family ‘rescues’
677 memory performance [67]. In miR-34a knockout/amyloid
678 precursor protein/presenilin 1 mice (APP/PS1), it has been
679 confirmed that miR-34a is involved in synaptic deficits in
680 AD pathological development, partially due to inhibition of
681 NMDA and AMPA receptor expression [68]. Although the
682 latter experiments are carried out in transgenic animals, they
683are consistent with our observed decrease in synaptic efficacy.
684In sporadic AD, up-regulated miR-34a in the neocortex ap-
685pears to down-regulate SHANK3, a postsynaptic scaffolding
686protein essential to post-synaptic structure and function [69,
68770]. Others have shown that stable hippocampal miR-34a in-
688hibition using adeno-associated virus-delivered miRNA
689sponges demonstrates transcriptome changes linked to neuro-
690active ligand-receptor transduction in cell communication,
691causing decreased capacity of reference memory in mice
692[27]. Supporting our findings, bioinformatical analyses de-
693scribed by Sarkar et al showed that miR-34a has the ability
694to affect molecular processes that are intrinsically linked to the
695regulation of pre- and post-synaptic neuronal excitability and
696resting state functional connectivity [15]. The same authors
697have also described that targets for miR-34a were profoundly
698reduced by miR-34a over-expression leading to cognitive de-
699cline and disease neuropathology [71]. Recently, it has been
700suggested that increasing Arc levels prior to the development
701of AD neuropathology could protect against cognitive impair-
702ment that accompany AD neuropathology [64]. Our results
703revealed that antimiR-34a infusion during basal conditions
704acutely depresses MMP-evoked fEPSPs due to sequence-
705specific mechanisms, a phenomenon that was absent during
706long-term potentiation. Multiple synaptic targets, including
707miR-34a target Arc, were upregulated during basal conditions,
708adding new knowledge to the complexity of miR-34a function
709in synaptic efficacy and plasticity. We realize that the temporal
710and spatial distribution of miR-34a and modulation of its tar-
711gets is highly heterogeneous and serve multiple synaptic
712mechanistic systems and cognitive trajectories.
713Conclusion
714Our results identify a set of miR-34a targets associated with
715regulation of basal synaptic transmission in the dentate gyrus.
716Further work is needed to elucidate the potential causal role of
717these specific miR34a targets. The results described in this
718study are novel in the field of microRNA regulation and syn-
719aptic transmission. Current knowledge on miRNA function in
720synaptic plasticity and transmission in vivo is predominately
721based on long-term manipulations. To our knowledge,
722no other study has demonstrated that miRNAs are in-
723volved in acute regulation of synaptic transmission
724in vivo. We conclude that miRNAs can generate rapid
725neuronal responses and, in this way, are ideally posi-
726tioned to modulate synaptic efficacy.
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